SMTL ID : 3h2l.1 (1 other biounit)

Crystal structure of HCV NS5B polymerase in complex with a novel bicyclic dihydro-pyridinone inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x YAK: N-{3-[(4aR,7aS)-1-(4-fluorobenzyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-cyclopenta[b]pyridin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide(Non-covalent)

YAK.1: 19 residues within 4Å: Chain A: F.193, P.197, R.200, S.288, N.291, N.316, G.317, D.318, D.319, C.366, S.368, L.384, M.414, Y.415, Q.446, I.447, Y.448, G.449, S.556 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:D.319, A:M.414, A:Y.415, A:Y.448 Hydrogen bonds: A:N.291, A:D.318, A:D.318, A:Y.448, A:G.449 Water bridges: A:S.556 pi-Stacking: A:F.193

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ruebsam, F. et al., Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-12-08

Peptides

NS5B polymerase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

NS5B polymerase

Related Entries With Identical Sequence